Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat
- 31 March 1988
- journal article
- Published by Elsevier in Journal of Diabetic Complications
- Vol. 2 (1) , 16-18
- https://doi.org/10.1016/0891-6632(88)90020-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987
- Microalbuminuria as a predictor of clinical diabetic nephropathyKidney International, 1987
- N-[[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitorJournal of Medicinal Chemistry, 1984
- Urinary excretion of albumin and total protein in normal and streptozotocin diabetic ratsActa Endocrinologica, 1980
- Amelioration of Mesangial Volume and Surface Alterations Following Islet Transplantation in Diabetic RatsDiabetes, 1980
- Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatmentDiabetologia, 1979
- Determination of membrane thickness distribution from orthogonal interceptsJournal of Microscopy, 1979
- Effects of Pancreatic Islet Transplantation on the Increased Urinary Albumin Excretion Rates in Intact and Uninephrectomized Rats with Diabetes MellitusDiabetes, 1978
- Hyperglycemia, Polyol Metabolism, and Complications of Diabetes MellitusAnnual Review of Medicine, 1975
- RENAL TRANSPLANTATION IN DIABETES MELLITUS IN RATSThe Journal of Experimental Medicine, 1974